| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.03 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.064 | 0.03 |